Low Molecular Weight Heparin in Sufficient Dose of ≥70 IU/kg as an Effective and Safe Thromboprophylaxis in Patients with Newly Diagnosed Multiple Myeloma during Conventional VAD Induction Therapy.

@inproceedings{Pour2007LowMW,
  title={Low Molecular Weight Heparin in Sufficient Dose of ≥70 IU/kg as an Effective and Safe Thromboprophylaxis in Patients with Newly Diagnosed Multiple Myeloma during Conventional VAD Induction Therapy.},
  author={Luděk Pour and MUDr.Petr Kessler and Ev{\vz}en Gregora and Mark{\'e}ta Zemanov{\'a} and Miroslav Penka and Jarom{\'i}r Gumulec and Z Weber Adam and Bacovsky Jaroslav and Hana Fraňkov{\'a} and Kamila Havl{\'i}kov{\'a} and F. Lehanka and Vladim{\'i}r Maisnar and I. Meluz{\'i}nov{\'a} and Yvetta Stavařov{\'a} and Jan Straub and Adam Svobodn{\'i}k and Vlastimil {\vS}{\vc}udla and Elena {\vS}umn{\'a} and Lenka Walterov{\'a} and Roman H{\'a}jek},
  year={2007}
}
Background: The patients with multiple myeloma (MM) have an increased risk of venous thromboembolism (VTE), particularly during the induction phase of therapy. Low molecular weight heparins (LMWH) seem to be useful for thromboprophylaxis in these patients. We analyzed prophylactic efficiency of LMWH based on dose either lower or higher than 70 IU/kg of body weight. Patients and Methods: 223 patients with newly diagnosed MM were treated with induction chemotherapy consisting of vincristine… CONTINUE READING